Pharmaceutical Pricing - Global Perspectives is a strategic report, that analyses all aspects of pharmaceutical pricing and reimbursement strategies through extensive use of case studies.
The pricing of new pharmaceutical products is crucial and must not be left to luck. If the price is set too high, the product may fail to gain reimbursement or be excluded from formularies. If the price is too low, profitability will be reduced. Thus, it is essential for pharmaceutical companies to fully understand the principles governing pricing and the market environment in which they are operating.
The report’s text is complimented with key case studies of how pharmaceutical companies have managed the prices of their key products, to ensure continued profitability in the light of competition and patent expiry, including:
Merck’s single European pricing scheme for Crixivan
Eli Lilly’s proactive strategy for patent expiry
The life-cycle of Genzyme’s Ceredase and Cerezyme
Upjohn’s sale of Dalacin in Denmark
Biogeneric competition to Epogen
In almost every country there is ongoing discussion about pharmaceutical pricing. This report examines the major regional issues including;
Europe - How parallel trade (‘grey market’) within the EU affects ethical manufacturer’s profitability. - Why inter-country reference pricing has grown in importance in Europe? - Is a European-wide pricing assessment body a realistic prospect?
North America - Will US follow the rest of the world and move away from free pricing and implement some controls. - Are the high prices achieved sustainable in the longer term and how are lower prices in Canada affecting the US political arena?
Rest of World - How the economic downturn and cost containment in Japan has hit the pharmaceutical industry hard. - Why the pharmaceutical industry has come under attack from countries where AIDS is prevalent. - How Brazil exploited international patent rules to produce its own generic medicines.
Five reasons why your organisation should invest in this report - Stay up-to-date with the latest trends in global pharmaceutical pricing & reimbursement - Learn common jargon and terminology used in the pricing & reimbursement fields - Gain insight into growing role of pharmacoeconomics in demonstrating the financial value of drugs - Forecast how governments will implement drug spending cost containment measures - Understand the increasing pressure from less developed countries to access drugs at lower prices
The text also contains detailed descriptions for issues and terms connected with pricing, which can be used as an encyclopaedia of terminology.
(0 items)
